共 217 条
[1]
Masoudi FA(2004)National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction Circulation 110 724-731
[2]
Rathore SS(2004)Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension Am J Cardiol 93 240-243
[3]
Wang Y(1995)Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 273 1450-1456
[4]
Havranek EP(2001)Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data Ann Intern Med 135 73-87
[5]
Curtis JP(1999)Angiotensin-converting enzyme gene I/D polymorphism and renal disease J Mol Med 77 781-791
[6]
Foody JM(1998)Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy Lancet 352 1252-1256
[7]
Krumholz HM(2004)Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review BMJ 329 828-1766
[8]
Angeli F(2002)Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition Transplant Proc 34 1763-320
[9]
Verdecchia P(2003)Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients Transpl Int 16 313-69
[10]
Reboldi GP(1998)Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease 156 Kidney blood press res 21 66-994